IP Library Granted Patent US 11,111,375
Granted Patent B2
US 11,111,375 · App. 15/758,231 · Granted Sep 7, 2021

Compositions and methods for generating oligodendrocyte precursors

Inventors: Gonçalo Rodrigues (Berkeley, CA); David V. Schaffer (Danville, CA)
Assignee: The Regents of the University of California
C08L51/006C07D471/04C12N5/0018C12N5/0622A61K35/28C08L2203/02C12N2501/385C12N2501/41C12N2501/415C12N2506/02C12N2506/45C12N2539/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,111,375
App. No.
15/758,231
Granted
Sep 7, 2021
Kind
B2
Abstract

The present disclosure provides a three-dimensional culture system comprising a biocompatible polymer and a combination of factors in an amount effective to induce differentiation of oligodendrocyte precursors and/or oligodendrocytes from pluripotent stem cells. The present disclosure provides methods of generating oligodendrocyte precursors and/or oligodendrocytes using a three-dimensional culture system of the present disclosure. The present disclosure provides methods to treat neurological diseases and demyelinating diseases.

Claims (29)

1. A three-dimensional culture system comprising:

a) biocompatible thermoresponsive polymer that forms a hydrogel at 37° C.; and

b) a combination of factors that promote differentiation of oligodendrocyte precursors from pluripotent stem cells in 20 days or less, wherein the combination of factors consists of a Sonic hedgehog (Shh) signaling pathway agonist and retinoic acid (RA); and

wherein the thermoresponsive polymer comprises:

an N-isopropylacrylamide co-monomer;

an alkyl [meth]acryl[ate/amide] co-monomer, wherein the alkyl is a lower alkyl group;

a PEG acrylamide co-monomer; and

a modifying acryl[ate/amide] co-monomer comprising a linked functional group or a linked modifying agent,

wherein the thermoresponsive polymer is described by formula (II):

wherein:

a, b, c and d are molar fractions of the co-monomers, wherein a >0.8, 0.1>b>0, and 0.2>c>0;

PEG n is a polyethylglycol polymer;

Z 2 is a functional group or a linked modifying agent;

L is a linker;

R 1 is a lower alkyl;

G 1 and G 2 are each independently selected from a polymer segment, a terminal group, a linker and a linked modifying agent.

2. The culture system of claim 1 , wherein:

the Shh signaling pathway agonist is 3,4-dichloro-N-(cis-4-(methylamino)cyclohexyl)-N-(3-pyridin-4-ylbenzyl)benzo[b]thiophene-2-carboxamide, an Shh polypeptide, an Shh protein-polymer conjugate, or a compound of the formula:

3. The culture system of claim 1 , comprising a pluripotent stem cell.

4. The three-dimensional culture system of claim 1 , wherein the Shh signaling pathway agonist is a small molecule.

5. The three-dimensional culture system of claim 1 , wherein the alkyl [meth]acryl[ate/amide] co-monomer is an isobutyl methacrylate co-monomer.

6. The three-dimensional culture system of claim 1 , wherein R 1 is selected from the group consisting of methyl, ethyl, propyl, butyl, pentyl, isopropyl, isobutyl, isopentyl, tert-butyl, cyclopropyl, and cyclobutyl.

7. The three-dimensional culture system of claim 1 , wherein Z 2 is a chemoselective functional group.

8. The three-dimensional culture system of claim 1 , wherein the thermoresponsive polymer is described by the formula (IV):

9. The three-dimensional culture system of claim 1 , wherein G 1 and G 2 are each independently selected from a terminal group, a linker and a linked modifying agent.

10. The three-dimensional culture system of claim 1 , wherein G 1 , G 2 or Z 2 comprise a linked hyaluronic acid that is linked via conjugation to the carboxylic acid group of a hyaluronic acid monomer.

11. The three-dimensional culture system of claim 1 , wherein G 1 , G 2 or Z 2 comprise the following structure:

12. The three-dimensional culture system of claim 11 , wherein Z 2 comprises the following structure:

13. The three-dimensional culture system of claim 1 , wherein G 1 and/or G 2 comprises the following structure:

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 17, 2018
From: RODRIGUES, GONÇALO; SCHAFFER, DAVID V.
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 045836/0860 →
Continuity (2)
Provisional Application 62237441 · Oct 5, 2015
Related Publication 20180251730A1 · Sep 6, 2018